Rubius Therapeutics

About Us
Our Science
Our Pipeline
Investors & Media
Careers
Contact

Menu Search

Quarterly Results

Show all

2020

Q3

Rubius Therapeutics Reports Third Quarter 2020 Financial Results and Strong Execution Across the Pipeline
Form 10-Q

Q2

Rubius Therapeutics Reports Second Quarter 2020 Financial Results and Positive Progress Across Pipeline
Form 10-Q

Q1

Rubius Therapeutics Reports First Quarter 2020 Financial Results and Provides Operational Update
Form 10-Q

2019

Q4

Rubius Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Announces Strategic Focus on Oncology and Autoimmunity
Form 10-K

Q3

Rubius Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress
Form 10-Q

Q2

Rubius Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress
Form 10-Q

Q1

Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress
Form 10-Q

2018

Q4

Rubius Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results with Business Updates
Form 10-K

Q3

Rubius Therapeutics Reports Third Quarter 2018 Financial Results and Operational Progress
Form 10-Q

Q2

Rubius Therapeutics Reports Second Quarter 2018 Financial Results
Form 10-Q

Print Page

RSS Feeds

Share Page

Email Alerts

Contact Us

399 Binney St, Suite 300
Cambridge, MA 02139 617-679-9600

Share

LinkedIn Twitter

Home
About Us
Our Science
Our Pipeline
Investors
Careers
Sitemap
Terms of Use
Privacy Policy

© Rubius Therapeutics, Inc. 2021. All Rights Reserved. RUBIUS and RED PLATFORM are registered trademarks of Rubius Therapeutics, Inc. RUBIUS THERAPEUTICS, RED CELL THERAPEUTICS and RCT are trademarks of Rubius Therapeutics, Inc. All other trademarks referenced herein are the properties of their respective owners.

Facebook
Twitter
LinkedIn